Thats not what they are for
Combination of GLP1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
Conclusion GLP-1 agonists are pivotal in managing type 2 diabetes and supporting weight loss by mimicking natural hormonal actions that regulate insulin, glucose, and appetite
That means considering hormone balance, gut health, micronutrient status, and lifestyle factors alongside any advanced therapy
By this point, the peptide has established consistent signaling, and cumulative fat mobilization produces visible changes
In response to current food safety, the state has successively introduced relevant policies, and the implementation of prescription drugs and non-prescription drugs has imposed great restrictions on antibiotics